{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:59:58Z","timestamp":1793289598843,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhepr.2025.101451","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:26:49Z","timestamp":1746818809000},"page":"101451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["SBRT for bridging and downstaging HCC before transplant"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-7043","authenticated-orcid":false,"given":"Zhihao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-6563","authenticated-orcid":false,"given":"Michael","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-3119","authenticated-orcid":false,"given":"Marco P.A.W.","family":"Claasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2716-7121","authenticated-orcid":false,"given":"Luckshi","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-949X","authenticated-orcid":false,"given":"Christian T.J.","family":"Magyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5555-3102","authenticated-orcid":false,"given":"Saheli","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4638-3059","authenticated-orcid":false,"given":"Cameron","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Selzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Jaeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Ghanekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Cattral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blayne A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Selzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McGilvray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaya","family":"Shwaartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Reichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8690-403X","authenticated-orcid":false,"given":"Grainne M.","family":"O\u2019Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-1428","authenticated-orcid":false,"given":"Tae Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Soo-Yee","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hosni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruz","family":"Mesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Lukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2768-3350","authenticated-orcid":false,"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sapisochin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101451_bib1","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101451_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100129","article-title":"Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit","volume":"6","author":"Lee","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.jhepr.2025.101451_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.radonc.2020.11.033","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion","volume":"156","author":"Munoz-Schuffenegger","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"JCO"},{"key":"10.1016\/j.jhepr.2025.101451_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2016.02.027","article-title":"Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysis","volume":"95","author":"Bush","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2025.101451_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijrobp.2023.03.064","article-title":"Transarterial chemoembolization with drug-eluting beads versus stereotactic body radiation therapy for hepatocellular carcinoma: outcomes from a multicenter, randomized, phase 2 trial (the TRENDY Trial)","volume":"117","author":"Romero","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2025.101451_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.02.022","article-title":"Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis","volume":"67","author":"Sapisochin","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101451_bib9","unstructured":"National Cancer Institute. Common Terminology criteria for adverse events (CTCAE). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_60 [Accessed May 19, 2025]."},{"key":"10.1016\/j.jhepr.2025.101451_bib10","unstructured":"Innovasium. Trillium gift of life network - ontario\u2019s organ and tissue donation agency : search. https:\/\/www.giftoflife.on.ca\/resources\/pdf\/Adult_Liver_TxRefList_Criteria_V5.0_EN.pdf [Accessed June 16, 2025]."},{"issue":"4_suppl","key":"10.1016\/j.jhepr.2025.101451_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1200\/JCO.2023.41.4_suppl.489","article-title":"NRG\/RTOG 1112: randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC)","volume":"41","author":"Dawson","year":"2023","journal-title":"JCO"},{"key":"10.1016\/j.jhepr.2025.101451_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaoncol.2024.5403","article-title":"Stereotactic body radiotherapy vs sorafenib alone in hepatocellular carcinoma: the NRG Oncology\/RTOG 1112 phase 3 randomized clinical trial","volume":"11","author":"Dawson","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1432-2277.2009.00980.x","article-title":"Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma","volume":"23","author":"Sandroussi","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2025.101451_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/lt.23439","article-title":"Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation","volume":"18","author":"O\u2019Connor","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhepr.2025.101451_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13014-017-0899-4","article-title":"Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable hepatocellular carcinoma","volume":"12","author":"Moore","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib16","first-page":"261","article-title":"Stereotactic body radiotherapy used as a bridge to liver transplant in patients with hepatocellular carcinoma and Child-Pugh score \u22658 cirrhosis","volume":"5","author":"Gresswell","year":"2018","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.jhepr.2025.101451_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13014-020-01739-5","article-title":"Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series","volume":"16","author":"Wang","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib18","article-title":"Outcomes after stereotactic body radiation therapy as a bridging modality to liver transplantation for hepatocellular carcinoma","volume":"6","author":"Garg","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1754-9485.13509","article-title":"Refining stereotactic body radiation therapy as a bridge to transplantation for hepatocellular carcinoma: an institutional experience","volume":"67","author":"Chen","year":"2023","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15998","article-title":"Stereotactic body radiotherapy and liver transplant for liver cancer: a nonrandomized controlled trial","volume":"7","author":"Lee","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jhepr.2025.101451_bib21","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1245\/s10434-008-9851-z","article-title":"Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation","volume":"15","author":"Facciuto","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101451_bib41","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.hpb.2019.10.006","article-title":"Liver transplant mortality and morbidity following preoperative radiotherapy for hepatocellular carcinoma","volume":"22","author":"Hasan","year":"2020","journal-title":"HPB"},{"key":"10.1016\/j.jhepr.2025.101451_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamaoncol.2018.6993","article-title":"Measuring the integration of stereotactic ablative radiotherapy plus surgery for early-stage non\u2013small cell lung cancer: a phase 2 clinical trial","volume":"5","author":"Palma","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijrobp.2017.09.001","article-title":"Stereotactic body radiation therapy as an alternative to transarterial chemoembolization for hepatocellular carcinoma","volume":"100","author":"Sapir","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jhepr.2025.101451_bib24","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.3390\/curroncol29110692","article-title":"Stereotactic radiotherapy after incomplete transarterial (chemo-) embolization (TAE\\TACE) versus exclusive TAE or TACE for treatment of inoperable HCC: a phase III trial (NCT02323360)","volume":"29","author":"Comito","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"JCO"},{"key":"10.1016\/j.jhepr.2025.101451_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jhep.2020.03.005","article-title":"Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma","volume":"73","author":"Kim","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101451_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/hepr.13647","article-title":"Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: systematic review and meta-analysis of propensity score studies","volume":"51","author":"Eriguchi","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhepr.2025.101451_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial","volume":"74","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101451_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.adro.2015.12.003","article-title":"Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma","volume":"1","author":"Mohamed","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib30","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/hep.31992","article-title":"Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"issue":"15_suppl","key":"10.1016\/j.jhepr.2025.101451_bib31","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.e15677","article-title":"A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) as a bridge to transplant in hepatocellular carcinoma (HCC)","volume":"35","author":"Nugent","year":"2017","journal-title":"JCO"},{"issue":"15_suppl","key":"10.1016\/j.jhepr.2025.101451_bib32","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1200\/JCO.2020.38.15_suppl.4586","article-title":"A randomized phase II feasibility study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC)","volume":"38","author":"Nugent","year":"2020","journal-title":"JCO"},{"key":"10.1016\/j.jhepr.2025.101451_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1245\/s10434-021-10278-6","article-title":"Stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) as a bridge to transplant in unresectable hepatocellular carcinoma","volume":"29","author":"Verbus","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhepr.2025.101451_bib34","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2021.07.033","article-title":"Downstaging outcomes for hepatocellular carcinoma: results from the multicenter evaluation of reduction in tumor size before liver transplantation (MERITS-LT) consortium","volume":"161","author":"Mehta","year":"2021","journal-title":"Gastroenterology"},{"issue":"20","key":"10.1016\/j.jhepr.2025.101451_bib35","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101451_bib36","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jhepr.2025.101451_bib37","doi-asserted-by":"crossref","first-page":"100498","DOI":"10.1016\/j.jhepr.2022.100498","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: from infancy to ongoing maturity","volume":"4","author":"Lewis","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101451_bib38","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/SLA.0000000000006038","article-title":"Novel benchmark for adult-to-adult living-donor liver transplantation: integrating Eastern and Western experiences","volume":"278","author":"Li","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2025.101451_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/SLA.0000000000002477","article-title":"Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results","volume":"267","author":"Muller","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2025.101451_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2021.10.004","article-title":"A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation","volume":"76","author":"Schlegel","year":"2022","journal-title":"J Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T08:08:45Z","timestamp":1755245325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2589555925001296"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101451","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SBRT for bridging and downstaging HCC before transplant","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101451"}}